What’s Hot at ECNP 2017 Congress?

PARIS — The role of epigenetics in disease etiology, stress and resilience in psychiatric disorders, and the growing importance of technology in treatment will form three of the central themes of a leading congress for neuroscientists, psychiatrists, neurologists, and psychologists.

The 30th European College of Neuropsychopharmacology (ECNP) Congress, which takes place in Paris on September 2 – 5, focuses on the science and treatment of brain disorders and will bring together up to 6000 attendees from around the world.

The program will feature 35 scientific symposia, seven educational sessions, and a plethora of brainstorming sessions, expert science exchanges, plenary lectures, and career development sessions, among others, across 4 days. In addition, more than 1000 posters will be presented.

The congress is organized by the ECNP, an independent scientific association that focuses on the science and treatment of brain disorders, and a noninstitutional supporter of neuroscience research and education in Europe.

Astrid Linthorst, PhD, professor of neuroscience at the University of Bristol, United Kingdom, and chair of the Scientific Program Committee at ECNP 2017, told Medscape Medical News that the program will be very interesting “for all kinds of attendees, whether they are basic scientists or clinical researchers or practicing psychiatrists.”

Terror Attacks Addressed

For Dr Linthorst, one of the highlights of this year’s program is the first symposium of the congress, which will be conducted on Saturday afternoon. At this patient session, terror attacks and the subsequent treatment of patients will be discussed. It will focus on what should, and should not, be done in the “golden hours” after an attack.

Following the opening scientific symposia and educational sessions, John H. Krystal, MD, chair of the Department of Psychiatry at the Yale University School of Medicine and chief of psychiatry at Yale—New Haven Hospital, will give the keynote lecture on Saturday evening, on glutamate targeting in psychiatric disease.

There will also be a series of plenary lectures throughout the 4-day congress, not least of which will be the ECNP Neuropsychopharmacology Award lecture on Monday afternoon, entitled “A Journey Into Serotonin: 40 Years of Discoveries and Surprises.”

Dr Linthorst believes this lecture, which will be given by Michel Hamon, PhD, director of research…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *